Blog
RSS FeedPosted by Michael Wonder on 18 Apr 2024
FINOSE now covers all Nordic countries
18 April 2024 - Icelandic Landspitali joins the Nordic collaboration FINOSE, where HTA authorities from the Nordic countries carry out ...
Posted by Michael Wonder on 18 Mar 2024
Co-design of an enhanced consumer engagement process
18 March 2024 - A consumer-led Co-design Working Group has developed proposed recommendations for enhancing consumer engagement processes to enable ...
Posted by Michael Wonder on 04 Mar 2024
Together for high standards in the assessment of health technologies in Europe from 2025
1 March 2024 - A few months before the EU HTA regulation came into force, a delegation from the French HTA ...
Posted by Michael Wonder on 07 Feb 2024
FDA and EMA launch parallel scientific advice pilot program for complex generics
7 February 2024 - CDER’s Office of Generic Drugs and the EMA launched a voluntary pilot program to facilitate concurrent discussions ...
Posted by Michael Wonder on 06 Feb 2024
Updates on NICE and SMC collaboration on MTA for cystic fibrosis
1 February 2024 - On 19 December 2023, we advised that NICE would be liaising with key stakeholders to determine ...
Posted by Michael Wonder on 25 Jan 2024
PHARMAC joins global health technology assessment network
25 January 2024 - PHARMAC has joined the International Network of Agencies for Health Technology Assessment (INAHTA) - a network ...
Posted by Michael Wonder on 03 Jan 2024
MHRA’s new international recognition procedure goes live from 1 January 2024
2 January 2024 - In partnership with other global regulators, the international recognition procedure is expected to further help bring life-saving ...
Posted by Michael Wonder on 10 Nov 2023
MHRA joins global regulatory partners in celebrating ten years of international medicines regulatory cooperation
9 November 2023 - As a founding member and former chair of the International Coalition of Medicines Regulatory Authorities (ICMRA), the MHRA ...
Posted by Michael Wonder on 02 Nov 2023
FDA notes “continued growth” of Orbis collaborative review program, adds EMA as observer
1 November 2023 - There has been “continued growth” in the number of applications submitted to Project Orbis, and the ...
Posted by Michael Wonder on 20 Oct 2023
Ethical and legal considerations in social media research for health technology assessment: conclusions from a scoping review
20 October 2023 - The objective was to identify and describe the published guidance and current academic discourse of ethical issues ...
Posted by Michael Wonder on 20 Sep 2023
International HTA collaboration expands
20 September 2023 - The international collaboration between six health technology assessment bodies from across the UK, Australia and Canada ...
Posted by Michael Wonder on 12 Sep 2023
MHRA’s new International Recognition Procedure: how does it shape up?
12 September 2023 - The field of life sciences and medicine development has become increasingly global. Multinational firms must make informed ...
Posted by Michael Wonder on 24 Aug 2023
International heath technology assessment collaboration expands
24 August 2023 - The international collaboration between six health technology assessment bodies from across the UK, Australia and Canada has ...
Posted by Michael Wonder on 10 Aug 2023
Patient and citizen participation at the organisational level in health technology assessment: an exploratory study in five jurisdictions
8 August 2023 - While patient participation in individual health technology assessments has been frequently described in the literature, patient and ...
Posted by Michael Wonder on 28 Jul 2023
CDER collaborates with global regulators on pharmaceutical quality assessments and inspections
28 July 2023 - The FDA and the EMA recently completed the first collaborative assessment of a proposed post-approval change ...